0.9859 USD
+0.03 (+3.37%)
ChartMill assigns a Buy % Consensus number of 83% to CRDL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.82. This target is 591.71% above the current price.
CRDL was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRDL.
In the previous month the buy percentage consensus was at a similar level.
CRDL was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-02 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | Roth MKM | Initiate | Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Initiate | Buy |
| 2023-08-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2021-12-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-12-03 | Canaccord Genuity | Initiate | Buy |
CARDIOL THERAPEUTICS INC-A / CRDL FAQ
What is the price target for CRDL stock?
8 analysts have analysed CRDL and the average price target is 6.82 USD. This implies a price increase of 591.72% is expected in the next year compared to the current price of 0.9859.
What is the consensus rating for CARDIOL THERAPEUTICS INC-A (CRDL) stock?
The consensus rating for CARDIOL THERAPEUTICS INC-A (CRDL) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CARDIOL THERAPEUTICS INC-A (CRDL)?
The number of analysts covering CARDIOL THERAPEUTICS INC-A (CRDL) is 8.